APA (7th ed.) Citation

Wang, M., Tsai, C., Wu, B., Lin, C., & Wang, Y. (2016). PRS4 - Risk Of Cardiovascular Diseases From Add-On Of Inhaled Tiotropium To Combined Therapy Of Inhaled Corticosteroids And Long-Acting Beta-Agonists In Chronic Obstructive Pulmonary Disease Patients. Value in Health, 19(3), A110. https://doi.org/10.1016/j.jval.2016.03.424

Chicago Style (17th ed.) Citation

Wang, M., C. Tsai, B. Wu, CW Lin, and Y. Wang. "PRS4 - Risk Of Cardiovascular Diseases From Add-On Of Inhaled Tiotropium To Combined Therapy Of Inhaled Corticosteroids And Long-Acting Beta-Agonists In Chronic Obstructive Pulmonary Disease Patients." Value in Health 19, no. 3 (2016): A110. https://doi.org/10.1016/j.jval.2016.03.424.

MLA (9th ed.) Citation

Wang, M., et al. "PRS4 - Risk Of Cardiovascular Diseases From Add-On Of Inhaled Tiotropium To Combined Therapy Of Inhaled Corticosteroids And Long-Acting Beta-Agonists In Chronic Obstructive Pulmonary Disease Patients." Value in Health, vol. 19, no. 3, 2016, p. A110, https://doi.org/10.1016/j.jval.2016.03.424.